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over 1 h, using a beat-to-beat QT and RR interval measurement, may 
not apply to the next hour in the same patient. This may oi:ur because 
RR-QT data collected during the course of the day L ’ (1’ .$how 
considerable scatter because of the normal fluctuations 1,: ,iuto- 
nomic tone. With this in mind, one really wonders whether correcting 
the QT interval makes any sense at all? 
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of greater importance in arrhyrhmogenesis, in clinical practice one 
shoild be abie to evaluate the QT interval in the rest ECG reliably. 
Moreover, the QT interval in the rest ECG is the key to understanding 
QT dynamics. When the most reliable QT interGal-adjusting tools for 
rest ECGs for different populations of patients under medication are 
needed, they should be constructed for the particular population using 
the principle presented. for example. When the effects of medication 
or the disease process on the QT interval in an individual patient have 
to be evaluated, we recommend the Holter method (3). 
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We thank Sarma et al. and J. Singh for their comments on our recent 
pub!ication in the Journal (1) The inaccuracy of Bazett’s method for 
adjusting QT intervals has caused bias in research and confusion in 
clinical practice. The popularity of the Bazett equation is based on its 
simplicity, not on its fit. The newer improved but complex methods 
have largely been ignored. Our goal was to create a simple and 
aLcurate method to compare QT intervals of rest electrocardiograms 
(ECGs) without violating the electrophysiologic principles derived 
from action potential studies (2). 
Sarma et al. derived an exponential equation using our data. Their 
equation produces an average mean-squared residual value of 304, 
whereas our nomogram method gives the value of 291 in young men 
(Table 3 [I]). Notwithstanding the possible advantages at very low 
heart rat::, the use of an exponential equation is problematic in 
clinical practice, which is why we avoided presenting one. The major 
advantage of the nomogram method is tliat i, is empiric and has no 
limiting preassumptions. The disadvantage of all regression equations 
is that the same rule is applied over the entire range of heart rates. 
As pointed out by J. Singh, the nomogram works at steady state 
only. This was ensured in our study by recording ECGs at rest, as 
stated in the report’s title. Estimating the patient’s QT interval at a 
different heart rate, a question raised by Sarma et al., is really another 
matter, as shown in Figure 7 in our study (I). 
Sarma et al. write that there is an insurmountable limitation to our 
method for estimating the QT interval in patients using class III 
antiarrhythmic drugs, whereas J. Singh reminds us that the nomogram 
presented may be inapplicable in disease states. These are important 
issues, similarly aqy!irPble to all equ&ons for adjusting QT intervals. 
If the goal is to evaluate the e&ct ai .untLrrh$~mic drugs or a disease 
process on the QT interval, then the Holter method should be chosen 
(3,4). In the Halter method the nezd for heart rate adjustment is 
avoided by measuring the QT intervais at the same spontaneous heart 
rates before and after intervention. 
J. Singh asks whether there is any sense at ali in correcting the QT 
interval. Because there is no such thing as a single correct QT interval, 
we preferred the term adjusted QT intenlaal. Although the dynamic 
changes in the QT interval and the dispersion of repolarization may be 
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Atrial Function Can Only Be Assessed by 
Combined Use of Volume- and 
Pressure-Assessing Noninvasive Methods 
In the recent study of Manning et al. (1) a new index for assessing the 
atrial contribution to diastolic performance was introduced. Using 
Newton’s second law of motion and variables derived from two- 
dimensional imaging and Doppler echocardiography, the authors 
attempted to introduce a more accurate mode of assessing atria1 
function in 29 patients after elective cardioversion for atrial fibrillation. 
When Newton’s law is replaced hy echocardiographic variables, the 
“atrial ejection force” is proportional to peak A velocity squared and 
varies directly with mitral orifice area. Although the atrial ejection 
force was found to he significantly reduced in the patients compared 
with a small group of normal control subjects, this new index does not 
represent an assessment of “atrial function” or “atrial contribution” in 
these patients with coronary and hypertensive heart disease because 
there are several problems with the interpretation of this major finding 
by the authors. 
Manning et al. mention that, according to data of Choong et al. (2), 
“peak A wave ve!ocity is over a physiologic range relatively indepen- 
dent cf ventricular preload.” However, they do not emphasize another 
important finding, namely that in patients with clearly abnormal 
diastolic function and elevated ventricula: filling pressures, peak A 
velocity is predominantly, if not exclusively, dependent on the degree 
of elevation of end-diastolic pressure. Obviously, the patients in the 
Manning et al. study could be expected to have at least a moderate 
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increase in end-diastolic pressure. Using simultaneous Doppler echo- 
cardiographic%d apexcardiographic recordings, we have previously 
reported (3,4) that in patients with coronary and hypertensive heart 
disease, a decreased peak A flow velocity is most frequently associated 
with a significantly elevated apexcardiographic A wave height. Accord- 
ing to our data, atria1 systolic function, which is given by the “gener- 
ation of pressure” and assessed by the relative height of the apexcar- 
diographic A wave, is not decreased but significantly increased in such 
patients. Consequently, the decrease in flow through the mitral valve 
during atria1 contraction in this clinical setting does not reflect a 
diminished power of atrial contraction; rather. it is the result of 
elevated ventricular tilling pressures only. Thus, “true atria1 function” 
can be evaluated only by an additional assessment of the power of 
“pressure generation” and the resulting “atrial kick” by the use of 
apexcardiographic recordings. These alternative fundamental patho- 
physiologic aspects, which have been extensively analyzed by many 
investigators using various techniques, were entirely neglected by 
Manning et al. By excluding these important data from the interpre- 
tation and discussion of their findings, the authors arrived at false 
conclusions about the nature and definition of atria1 function itself. 
A combined Doppler echocardiographic and apexcardiographic A 
wave index would probably help greatly in providing a clinically useftil 
evaluation of “true atrial function.” Such an index could be. for 
example, the ratio of the relative A wave to total height of apexcar- 
diogram and the peak A flow velocity; the former provides information 
about the force of “pressure generation” and the latter about the 
“change in flow” during atrial contraction. 
We hope that our previous work using both Doppler (flow) and 
apexcardiographic (pressure) A waves will stimulate the development 
of such combined indexes for accurately evaluating the “true atrial 
function and performance,” which can only be assessed when both 
parts of the equation are given. 
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In our report (1) we define atlial ejection force as “that force exerted 
by the left atrium in propelling blood into the left ventricle during 
atria1 systole . . . and should not be misinterpreted as an assessment of 
‘total’ atrial force.” Total atrial force would be the vector sum of all 
forces acting within the atrium. Utilizing echocardiographic variables, 
atrial ejection force is prc=ortional to peak A velocity squared. 
We agree that peak A velocity is frequently elevated among 
patients with heart disease. Because pe%k A velocity may be increased 
among patients with coronary and hypertenswe heart disease, one 
would then have expected atria1 ejection force to be increased in the 
study group (compared with control subjects), yet it was significantly 
depressed after cardioversion and continued for at !east I week after 
cardioversion. With each patient used as their own control, atrial 
ejection force significantly increased during the succeeding period of 
observation. To explain our findings on the basis of changes in filling 
pressure alone, one wuiild ha-e to hypothesize that left atrial filling 
pressure increased during the month after cardioversion. It is more 
likely that filling pressures declined (2). Thus, through the use of 
longitudinal data, we are comfortable in aarming the validity of atrial 
ejection force as an index of atria1 systolic function. We are unaware of 
serial apexcatdiogtaphic data among patients undergoing cardiover- 
sion and cannot be certain how this variable would change. Because 
the height of the apexcardiographic A wave is more closely related to 
ventricular stiffness, end-diastolic pressure and the volume 0: atrial 
sys!olic flow, concordance between it and atrial ejection force may be 
limited. 
We fully appreciate that “transmitral Doppler data alone do not 
fully reflect changes in ventricular compliance and . . a less compliant 
ventricle might present greater resistance to transmitral inflow and 
result in a depressed peak A wave velocity” (1). Better models are 
indeed needed, but because of the complexity of left ventricular 
diastolic and left atrial systolic function, one must carefully identify 
which components of cardiac performance are being assessed. 
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IIeparin and Aspirin in Unstable Angina: 
Insuficient Sample Size May Lead to 
Erroneous Conclusions 
In their article, Holdright et al. (1) address the interesting question 
whether, in patients with unstable angina, heparin combined wifh 
apirin is more effective in preventing transient myocardial ischemia 
than aspirin alone. The authors attack the current standard of practice 
in the United States, which is to use both aspirin and heparin (2). The 
authors, therefore. have the burden of proof. 
Holdright et ai. conclude that ‘-combined therapy with heparin and 
aspirin compared with aspirin aione makes no difference in the 
development of [transient myocardial ischemia].” Strikingly. their data 
shown in Table 2 (1) suggest just the opposite. The number of patients 
with at least one episode of transient mycc&rdial ischemia was 2% less 
in the heparin plus aspirin group than in the aspirin alone group, 18% 
vs. 24% of patients, respectively. Even more strikingly, this pattern was 
consistent in every single variable presented by the authors. The total 
number of episodes in the heparin plus aspirin group was less by 354, 
the median duration of episodes shorter by 16%; the total duration of 
